Skip to main content

Table 1 Availability of anti-malarial and malaria blood testing among all public sector outlets screened

From: The malaria testing and treatment landscape in Benin

  Public health facility CHW Total public sectora
% (95% CI) % (95% CI) % (95% CI)
Availability of: N = 298 N = 145 N = 536
 Any anti-malarial 95.0 (90.3, 97.4) 59.4 (40.2, 76.1) 72.6 (58.1, 83.5)
 Quality-assured ACT 89.9 (83.9, 93.8) 54.8 (32.2, 75.7) 59.4 (43.6, 73.4)
 Quality ACT with the ‘green leaf’ logo 3.0 (0.9, 9.8) 0.6 (0.1, 4.3) 4.7 (2.0, 10.8)
 Sulfadoxine–pyrimethamine 73.9 (63.9, 81.9) 0.0 (–) 20.6 (14.9, 27.7)
 Oral quinine 87.7 (82.7, 91.3) 2.3 (0.4, 11.7) 33.2 (25.0, 42.6)
 Chloroquine 0.4 (0.1, 1.6) 0.0 (–) 1.3 (0.5, 3.5)
 Oral artemisinin monotherapy 0.0 (–) 0.0 (–) 0.0 (–)
 Artesunate injection 5.3 (1.6, 16.6) 0.0 (–) 1.3 (0.4, 4.1)
 Artemether injection 6.2 (2.1, 16.7) 0.0 (–) 5.5 (2.5, 11.8)
 Quinine injection 79.3 (69.5, 86.5) 4.5 (0.8, 22.1) 32.2 (23.9, 41.9)
Availability of: N = 298 N = 145 N = 536
 Any diagnostic test 94.7 (90.1, 97.2) 68.4 (47.3, 84.0) 69.4 (56.9, 79.6)
 Microscopy 28.7 (21.4, 37.2) 0.9 (0.1, 5.1) 8.9 (6.0, 13.0)
 RDT 94.4 (89.8, 96.9) 68.4 (47.3, 84.0) 68.3 55.8, 78.7)
Readiness for malaria case management: N = 298 N = 145 N = 536
 Quality-assured ACT and malaria testing available 89.0 (82.7, 93.2) 49.7 (28.4, 71.2) 53.7 (39.2, 67.6)
 Quality-assured ACT no malaria testing available 1.0 (0.2, 3.6) 5.1 (2.3, 11.0) 5.7 (3.1, 10.2)
  1. aIncludes public non-for profit sector (N = 93)